MedPath

Effect of Bazedoxifene to osteoporotic patients under active vitamin D treatment

Phase 4
Recruiting
Conditions
osteoporosis
Registration Number
JPRN-UMIN000007398
Lead Sponsor
Gerontology Osaka City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients treated with bisphosphonates over 2 weeks within the previous 12 months; (2) Patients that had been treated with medications that may affect bone metabolism within the previous 3 months with exception to calcium and vitamin D; (3) Patients with allergic reaction to SERM or contraindication to SERM; (4) Patients with kidney dysfunction (serum creatinine >1.6mg/dl); (5) Acute phase of fracture; (6) Immobility

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath